At a glance
- Originator Fidia Farmaceutici
- Class Analgesics; Neuroprotectants; Small molecules
- Mechanism of Action Acetylcholinesterase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 10 Oct 2003 Discontinued - Preclinical for Pain in Italy (unspecified route)
- 22 May 2001 No-Development-Reported for Pain in Italy (Unknown route)
- 05 Aug 1998 New profile